Journal of Patient-Reported Outcomes (Mar 2022)

Development and content validation of a self-completed, electronic Pediatric Asthma Symptom Diary

  • Marci Clark,
  • Carla Romano,
  • Oyebimpe Olayinka-Amao,
  • Diane Whalley,
  • Rebecca Crawford,
  • Purnima Pathak,
  • Caterina Brindicci,
  • Kristin Garg,
  • Kattayoun Kordy,
  • Francois Everhard,
  • Francesco Patalano,
  • Zach Roesler,
  • Thomas Sutton,
  • Oskar Göransson,
  • Ross Landles,
  • Christel Naujoks,
  • Jessica Marvel,
  • Dorothy L. Keininger

DOI
https://doi.org/10.1186/s41687-022-00432-3
Journal volume & issue
Vol. 6, no. 1
pp. 1 – 13

Abstract

Read online

Abstract Background Childhood asthma is an important unmet need. To date, patient-reported outcome measures (PROMs) for children with asthma have used a combination of caregiver or proxy-reported and self-reported measures. No comprehensive measure is available to assess the severity and impact of daytime and nighttime asthma symptoms and rescue medication use for self-completion by children aged 6–11 years. This study aimed to develop a novel, interactive, electronic Pediatric Asthma Symptom Diary (ePASD) measuring self-reported key symptom severity and proximal impacts of asthma in young children with varying reading ability and disease severity, consistent with US Food and Drug Administration (FDA) PRO guidance and the International Society for Health Economics and Outcomes Research (ISPOR) good research practices. Methods A targeted literature review and clinician interviews were undertaken to characterize symptoms and impacts experienced by children with mild-to-severe asthma. Concept elicitation interviews (CEIs) were conducted with 44 children and their caregivers (30 US; 14 UK). Following item and digital application development, the ePASD was assessed for relevance, understanding, and interpretability through cognitive debriefing interviews (CDIs) with 21 US children. Face validity/translatability assessments were also performed. Results Key measurement concepts included cough, wheeze, difficulty breathing, chest tightness/discomfort, nighttime awakening, and daytime activity limitations. Concept saturation was reached during CEIs for primary asthma-related daytime and nighttime symptoms and core impacts. Most CDI participants found the ePASD items clear, understandable, and comprehensive. Standardized training is anticipated to facilitate reliable child self-report. Conclusion The ePASD, a novel PROM for children aged 6–11 years with asthma, uses an innovative multimedia approach and has been developed in accordance with FDA PRO guidance and ISPOR good research practices, directly capturing the child’s self-reported asthma symptoms, impacts on daily activities and nighttime awakening, and rescue medication use.

Keywords